Biosensors Intl Grp (BSNRF) 0.5900 $BSNRF
Biosensors Announces Strategic Agreement With Cardinal Health
PR Newswire Europe - Thu May 12, 8:01AM CDT
Biosensors International Group, Ltd. ("Biosensors" or the "Company"
, a developer, manufacturer and marketer of innovative medical devices, today announced that it has entered into a strategic distribution agreement with Cardinal Health.
Vascular and Non-Vascular Stents: Global Market 2015 - Forecast to 2021
M2 - Mon Oct 19, 5:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cc3t5b/vascular_and) has announced the addition of the "Vascular and Non-Vascular Stents Global Market - Forecast to 2021" report to their offering. Stents are devices used in the body for treating weak or narrow blood vessels caused due to plaque formation. Stents helps in improvement of the blood flow and prevents the blood vessels from bursting. The global stents market is segmented based on the types, applications, materials, coatings, and geography. Based on the types, the stents are divided into bare metal stents, drug-eluting stents and bio-resorbable stents. By applications, the stents are divided into two segments as vascular and non-vascular stents. Vascular stents are further classified into coronary stents and peripheral stents. Peripheral stents are lower extremity & iliac stents, neurovascular stents and renal artery stents. Neurovascular stents sub segmented into carotid stents and intracranial stents. Non-vascular stents are divided into gastrointestinal, airway, urology and ophthalmology & other stents. Gastrointestinal stents are further segmented into pancreatic & biliary, esophageal, colorectal and duodenal stents. Urology stents are further segmented into ureteral & urethral stents and prostate stents. Depending on its materials, there are Metals and Polymers. Metals are segmented as cobalt-chromium, nickel-titanium, platinum-chromium, stainless steel and others whereas polymers are segmented as durable polymer and bio-absorbable polymers. Based on the coating, there are coated stents and non-coated stents. Coated stents are further segmented into inorganic, polymer, polymer-free and other coated stents. Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Analysis 4 Stents Market, By Types 5 Stents Market, By Application 6 Stents Market, By Materials 7 Stents Market, By Coatings 8 Regional Market Analysis 9 Company Developments 10 Major Player Profiles - Abbott Laboratories - B. Braun Melsungen Ag - Biosensors International Group - Biotronik Se & Co. Kg - Boston Scientific Corpoartion - C.R.Bard Inc. - Cook Medical Inc - Johnson & Johnson (Cordis Corporation) - Medtronic Inc - Microport Scientific Corporation - Olympus Corporation - Terumo Corporation For more information visit http://www.researchandmarkets.com/research/cc...scular_and
BSX: 23.89 (+0.03), JNJ: 123.22 (-0.55), ABT: 45.04 (-0.01), MDT: 87.54 (-0.26)
BioFreedom(TM) Drug-Coated Stent Demonstrates Superior Safety and Efficacy with One-Month of DAPT in Patients at High Bleeding Risk
PR Newswire - Wed Oct 14, 1:30PM CDT
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, announced today that the LEADERS FREE clinical trial demonstrated superior safety and efficacy for BioFreedom(TM) compared with a bare-metal stent (BMS). The results were presented by Dr. Philip Urban, Principal Investigator for LEADERS FREE, at the 27th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation, and simultaneously published in the New England Journal of Medicine.
Biosensors: BMX-J to Commercialize in Japan Starting October 2015
PR Newswire - Tue Sep 29, 7:45AM CDT
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced that the Company will commercialize its BMX-J drug-eluting stent (DES) system in Japan starting 1 October 2015.
Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016
PR Newswire - Mon Aug 03, 6:12AM CDT
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced financial results for its first fiscal quarter ended 30 June 2015 ("Q1 FY16" .
Biosensors Reports Financial Results for Fiscal Year 2015
PR Newswire - Wed May 27, 6:22AM CDT
Biosensors International Group, Ltd. ("Biosensors " or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced financial results for its fourth fiscal quarter ("Q4 FY15" and fiscal full year ended 31 March 2015 ("FY15" .
Global Biochemical Sensors Market Forecast and Opportunities 2015-2020
M2 - Fri May 08, 9:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ctbmsf/global) has announced the addition of the "Global Biochemical Sensors Market Forecast and Opportunities, 2020" report to their offering. The global biochemical sensors market is projected to reach USD23.3 billion by 2020 Electrochemical, optical, thermal, and piezoelectric are the major types of biochemical sensors used across diverse applications. Growing health concerns, declining cost of devices coupled with miniaturization of biochemical sensing devices are few of the major factors expected to drive demand for biochemical sensors over the next five years. High accuracy, easy usability, higher sensitivity even at low analyte concentrations are boosting the adoption of biochemical sensors across diverse end use applications. Growing need for low-cost, easy to use, fast and reliable analytical tools has been paving the way for use of biochemical sensors for quantitative and qualitative determination of discrete analytes in clinical, agricultural, environmental, food and defense applications. Presently, biochemical sensors are being predominantly used in medical applications, however, their adoption is increasing in agricultural, nutritional and environmental sectors due to continuous emphasis on improving product quality and growing need to comply with legislative guidelines. Increasing research & development activities, rising government emphasis and increasing advancements in healthcare infrastructure are expected to drive the sales of biochemical sensors over next five years. Global Biochemical Sensors Market Forecast & Opportunities, 2020 discusses the following aspects about the global biochemical sensors market: - Global Biochemical Sensors Market Size, Share & Forecast - Segmental Analysis - By Product Type (Electro-chemical, Thermal, Piezoelectic, Optical, etc.) and By End Use (Medical, Environmental, Nutritional & Agricultural) - Regional Analysis (North America, Europe, Asia-Pacific & Rest of World) - Changing Market Trends & Emerging Opportunities - Competitive Landscape & Strategic Recommendations Market Trends & Developments - Development of Silicon Microsensors - Development of Optical Fibers - Automotive Biochemical Sensors Technology - Growing Demand of Personalized Medicine - Miniaturization of Biochemical sensors - Integration of Wireless Communications Systems - Mass Production of Biochemical sensors Competitive Landscape - Company Shares - Abbott Point of Care Inc - Smiths Medical Md, Inc - LifeSensors Inc - LifeScan Inc. - Medtronic plc - Boston Scientific Corporation - Nova Biomedical Corporation - Acon Laboratories, Inc - Bio-Rad Laboratories, Inc - Universal Biosensors, Inc - Bayer AG - Pharmaco-Kinesis Corporation - SensLab - BioDetection Instruments, Inc - Biosensor Laboratories Incorporated - ABTECH Scientific, Inc - NeuroSky, Inc. - Biosensors International Group, Ltd - Roche Diagnostics - Sysmex Corporation - YSI Life Sciences For more information visit http://www.researchandmarkets.com/research/ctbmsf/global
BSX: 23.89 (+0.03), MDT: 87.54 (-0.26)
Global Drug Eluting Stents (DES) Pipeline Review 2015
M2 - Tue Apr 28, 3:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/k44d7d/drug_eluting) has announced the addition of the "Drug Eluting Stents (DES) - Pipeline Review, 2015" report to their offering. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key drug eluting stents pipeline products. Scope: - Extensive coverage of the Drug Eluting Stents products under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Drug Eluting Stents and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry The report enables you to: - Formulate significant competitor information, analysis, and insights to improve R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of Drug Eluting Stents under development - Develop market-entry and market expansion strategies - Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline - In-depth analysis of the product's current stage of development, territory and estimated launch date Companies Featured: - Abbott Vascular Inc. - AlviMedica Medical Technologies Inc. - Amaranth Medical, Inc. - Arterius Ltd - Biosensors International Group, Ltd. - BioSurfaces, Inc. - Biotronik SE & Co. KG - Boston Scientific Corporation - CARDIONOVUM GmbH - CID S.r.l. - Contego Medical, LLC - DISA Vascular (Pty) Ltd. - Elixir Medical Corporation - Envision Scientific Pvt. Ltd - Eurocor GmbH - HangZhou HuaAn Biotechnology Co.,Ltd - Icon Interventional Systems, Inc. - ICON Medical Corp. - InspireMD, Inc. - IRAMED GmbH - Lepu Medical Technology (Beijing) Co., Ltd. - Medinol Ltd. - Medtronic plc - Meril Life Sciences Pvt. Ltd. - Micell Technologies, Inc. - Minvasys - NanoCoeur, Inc. - Northwestern University - OrbusNeich - REVA Medical, Inc. For more information visit http://www.researchandmarkets.com/research/k4...ug_eluting
BSX: 23.89 (+0.03), MDT: 87.54 (-0.26), NSPR: 0.16 (unch)
Leading 100 Medical Devices/Technology/Supplies Companies of Emerging Markets 2015
M2 - Wed Apr 15, 7:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w5kc32/emerging_markets) has announced the addition of the "Emerging Markets Medical Devices/Technology/Supplies 100: An Industry Report" report to their offering. Medical technology aims to improve the quality of healthcare provided. Recent advances in this industry globally are focusing on cost reduction, less-invasive treatment options, and reduction in hospital stays and rehabilitation process. Emerging markets are widely recognized as one of the most important growth frontiers for medical devices. The healthcare industry has long seen that emerging markets have great untapped potential. In recent years many medical device companies have also begun to realize this potential and shift not only manufacturing but research and development to these emerging economies. The medical devices industry has exhausted its market territory in North America and Europe. Thus it is looking to expand into emerging markets which have shown promise due to increased demand for the healthcare industry, by the ageing population. Emerging markets are now considered one of the most important areas for growth for medical devices market. With this special industry report, our endeavor is to provide the new investors globally with a complete resourceful research report for familiarizing with the present investment trends of the Emerging Markets companies in the medical industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical devices/technology/supplies companies of Emerging Markets - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances among Emerging Markets medical devices/technology/supplies companies - International presence of Emerging Markets medical devices/technology/supplies companies - R&D activities by Emerging Markets medical devices/technology/supplies companies Key Topics Covered: 1. Rankings of Emerging Markets Medical Devices/Technology/Supplies Companies 2. Stock Market Performance over 5 Years. Leading 25 Emerging Markets Medical Devices/Technology/Supplies Companies 3. Key News of Emerging Markets Medical Devices/Technology/Supplies Companies for Year 2014 4. Important Alliances among Emerging Markets Medical Devices/Technology/Supplies Companies 5. International Presence of Emerging Markets Medical Devices/Technology/Supplies Companies 6. Research and Development Activities by Emerging Markets Medical Devices/Technology/Supplies Companies 7. Mergers and Acquisitions among Emerging Markets Medical Devices/Technology/Supplies Companies Companies Mentioned (Partial List) - Advanced Technology Company (Kuwait) - Biosensors International Group Ltd (Singapore) - CPC Diagnostics Pvt. Ltd (India) - Enjoyor Co., Ltd. (China) - Excelsior Medical Company Limited (Taiwan) - Ginko International Co Ltd (Taiwan) - Guangdong Shirongzhaoye Co Ltd (China) - Kossan Rubber Industries Berhad (Malaysia) - Largan Precision Company Limited (Taiwan) - MediVed Innovations Private Limited (India) - Mindray Medical International Limited (China) - Ningbo David Medical Device Co Ltd (China) - Optics India Equipments Private Limited (India) - Phoenix Medical Systems Private Limited (India) - Pneumo Care Health Private Limited (India) - PT Perdana Bangun Pusaka (Konica) Tbk (Indonesia) - PW Medtech Group Ltd (Hong Kong) - Remi Elektrotechnik Ltd. (India) - Sekonix Co Ltd (South Korea) - Servo-Med Industries Private Limited (India) - Shandong Pharmaceutical Glass Co Ltd (China) - Shandong Weigao Group Medical Polymer Co Ltd (Hong Kong) - Shanghai Tofflon Science and Technology Co Ltd (China) - South India Surgical Company Ltd (India) - Spectro Lab Equipments Pvt Ltd (India) - Syneron Medical Ltd. (Israel) - Toshvin Analytical Private Ltd (India) - Vimta Labs Ltd. (India) - Vinjoh Healthcare Private Limited (India) - Wadegati Labequip Private Limited (India) For more information visit http://www.researchandmarkets.com/research/w5...ng_markets
ELOS: 7.01 (+0.10), MR: 27.94 (+0.07)
Top 100 Asia Medical Devices/Technology/Supplies Companies 2015
M2 - Tue Apr 07, 4:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wttv9s/asia_medical) has announced the addition of the "Asia Medical Devices/Technology/Supplies 100: An Industry Report" report to their offering. Medical technology aims to improve the quality of healthcare provided. Recent advances in this industry globally are focusing on cost reduction, less-invasive treatment options, and reduction in hospital stays and rehabilitation process. Medical device companies remain bullish about Asian markets, driven by ageing populations, growing middle classes and government investments in healthcare. Strong demand for Asian medical devices has delivered sales growth of 44.1% compared to North/South America and Europe/Middle East/Africa. In 2012, the total value of the ASEAN medical device market was more than US $4 billion and the value is expected to increase to US $8 billion by 2017. With this special industry report, our endeavor is to provide the new investors globally with a complete resourceful research report for familiarizing with the present investment trends of the Asian companies in the medical industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical devices/technology/supplies companies of Asia - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances among Asian medical devices/technology/supplies companies - International presence of Asian medical devices/technology/supplies companies - R&D activities by Asian medical devices/technology/supplies companies Key Topics Covered: 1. Rankings of Asian Medical Devices/Technology/Supplies Companies 2. Stock Market Performance over 5 Years. Leading 25 Asian Medical Devices/Technology/Supplies Companies 3. Key News of Asian Medical Devices/Technology/Supplies Companies for Year 2014 4. Important Alliances among Asian Medical Devices/Technology/Supplies Companies 5. International Presence of Asian Medical Devices/Technology/Supplies Companies 6. Research and Development Activities by Asian Medical Devices/Technology/Supplies Companies 7. Mergers and Acquisitions among Asian Medical Devices/Technology/Supplies Companies Companies Mentioned - Partial List - Alfresa Pharma Corp (Japan) - Ansell Limited (Australia) - Arts Optical International Holdings Limited (Hong Kong) - AS ONE CORPORATION (Japan) - Asahi Intecc Co., Ltd. (Japan) - Beijing Wandong Medical Equipment Co. Ltd. (China) - Biosensors International Group Ltd (Singapore) - Blue Sail Medical Co Ltd (China) - CHC Healthcare Group (Taiwan) - China Medical System Hldgs Ltd (Hong Kong) - China Medicine Health Industry Co. Ltd (China) - China National Medicines Corp Ltd (China) - Citadel Research And Solutions Private Limited (India) - Claris Lifesciences Ltd. (India) - Cochlear Limited (Australia) - Confident Dental Equipments Limited (India) - Da An Gene Co Ltd of Sun Yat-Sen University (China) - Dipped Products Plc (Sri Lanka) - Ebos Group Limited (New Zealand) - Enjoyor Co., Ltd. (China) For more information visit http://www.researchandmarkets.com/research/wt...ia_medical
Top 100 Global Medical Devices/Technology/Supplies Not Active in India 2015
M2 - Thu Apr 02, 8:25AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dgm6pr/global_medical) has announced the addition of the "Global Medical Devices/Technology/Supplies Not Active in India 100" report to their offering. The global size of the medical devices sector is predicted to reach US $400 billion this year. However, India - a key player in the global pharmaceuticals industry, of which medical devices used to be covered - is underperforming. The country's market share stood at US $6.3 billion in 2013, contributing around 7-8 percent to overall healthcare spending in India as opposed to the 18 percent contributed by pharmaceuticals. With per capita spending estimated to be at less than US $3, it is understandable that the government feels FDI is the only way to spur domestic growth. Despite such figures, India's medical devices sector is expected to experience unprecedented growth during the next decade. By 2025, the industry is projected to be worth US $50 billion. This can be attributed to the country's growing middle class, an increase in the number of hospitals and, consequently, a greater need for sophisticated medical devices and better healthcare. With this special industry report, our endeavor is to provide the new investors globally with a complete resourceful research report for familiarizing with the present investment trends of the global companies in the medical devices/technology/supplies industry, which they would find beneficial to pursue for making business decisions in this sector in India. Highlights: - Leading global 100 medical devices/technology/supplies companies with no presence in India - Integration of company news and industry news, as well as rankings - Important M&A and alliances among global medical devices/technology/supplies companies not active in India - International presence of global medical devices/technology/supplies companies not active in India - R&D activities by global medical devices/technology/supplies companies not active in India Key Topics Covered: 1: Rankings of Global Medical Devices/Technology/Supplies Companies Not Doing Business in India News Section: 2: Key News of Global Medical Devices/Technology/Supplies Companies Not Doing Business in India for Year 2014 3: Alliances among Global Medical Devices/Technology/Supplies Companies Not Doing Business in India 4: International Presence of Global Medical Devices/Technology/Supplies Companies Not Doing Business in India 5: Research and Development Activities by Global Medical Devices/Technology/Supplies Companies Not Doing Business in India 6: Mergers and Acquisitions among Global Medical Devices/Technology/Supplies Companies Not Doing Business in India Companies Mentioned: Partial List - Abaxis Inc (United States) - Abiomed, Inc. (United States) - Advanced Technology Company (Kuwait) - Align Technology, Inc. (United States) - American Science and Engineering, Inc. (United States) - Angiodynamics, Inc. (United States) - Ansell Limited (Australia) - Arseus NV (Belgium) - Arts Optical International Holdings Limited (Hong Kong) - Atrion Corporation (United States) - Austar Lifesciences Ltd (Hong Kong) - Bastide le Confort Medical (France) - Biosensors International Group Ltd (Singapore) - Cantel Medical Corp. (United States) - China Medicine Health Industry Co. Ltd (China) - China National Medicines Corp Ltd (China) - Cooper Companies Inc (United States) - Create Medic Co., Ltd. (Japan) - Cremer SA (Brazil) - Cryolife, Inc. (United States) For more information visit http://www.researchandmarkets.com/research/dg...al_medical
ALGN: 95.65 (+1.02), ABAX: 49.65 (-0.05), ASEI: 36.94 (+0.20), CMN: 71.76 (+0.04), COO: 180.81 (-1.43)
CREDIT II Stent Trial Completes Enrollment
PR Newswire - Wed Mar 11, 7:59AM CDT
JW Medical Systems Limited ("JWMS" , a fully-owned subsidiary of Biosensors International Group, Ltd. ("Biosensors" or the "Company" (Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), has announced completion of patient enrollment in CREDIT II, the first randomized controlled trial ("RCT" involving the EXCEL II coronary stent. EXCEL II is the latest generation in the EXCEL family of biodegradable polymer drug-eluting stents ("BP-DES" , the leading BP-DES brand in China. Incorporating JWMS' latest technology, the EXCEL II stent features an abluminal coating of sirolimus combined with an optimized PLA biodegradable polymer, and is deployed from a new delivery system.
Top 100 Global Medical Devices Not Active in India: 2015 Industry Report
M2 - Mon Mar 09, 5:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3gp8dw/global_medical) has announced the addition of the "Global Medical Devices Not Active in India 100: An Industry Report" report to their offering. In India, with a rising population level and higher national growth rates and income levels, the demand for medical devices is expected to grow at a rate of over 15% per year. Though India presents an attractive market opportunity for global medical device manufacturers, the country has never been able to tap into its potential as a domestic manufacturing base. Despite having a medical device market that ranks in the world's top 20, the industry has a long history of being under-resourced. Recently, in a bid to boost investment in the $7 billion medical device sector, the Indian government announced that foreign companies could now fully own existing medical device manufacturers in the country, without the need to get prior approvals. This easing of existing regulations has been done to encourage foreign direct investment since the domestic capital market was not able to provide the much needed investment in this sector. The international companies in this field would now be able to use India as a manufacturing base easily by either setting up facilities of their own or by acquiring domestic manufacturers. FDI inflow will spur R&D and manufacturing innovations, in turn increasing the efficiency and effectiveness of medical electronic products. Advancement of medical electronic product quality and associated successful diagnostic rates are expected to create a spurt in adoption. Report Highlights: - Leading global 100 medical devices companies with no presence in India - Integration of company news and industry news, as well as rankings - Important M&A and alliances among global medical devices companies not active in India - International presence of global medical devices companies not active in India - R&D activities by global medical devices companies not active in India Companies Mentioned - Sample of the Top 100 Companies - A&T Corporation (Japan) - Abaxis Inc(United States) - Abiomed, Inc. (United States) - Advanced Technology Company (Kuwait) - Alphatec Holdings, Inc. (United States) - American Science and Engineering, Inc. (United States) - Atricure, Inc. (United States) - Atrion Corporation (United States) - Austar Lifesciences Ltd (Hong Kong) - Bastide le Confort Medical (France) - Baumer S.A. (Brazil) - Bioquell plc(United Kingdom) - Biosensors International Group Ltd (Singapore) - Canon Electronics Inc.(Japan) - China Medicine Health Industry Co. Ltd(China) - China Renji Medical Group Limited (Hong Kong) - China Resources Wandong Medical Equipment Company Limited (China) - Compumedics Limited (Australia) - Corgenix Medical Corporation(United States) - Create Medic Co., Ltd. (Japan) For more information visit http://www.researchandmarkets.com/research/3g...al_medical
ATEC: 0.36 (+0.01), ABAX: 49.65 (-0.05), ASEI: 36.94 (+0.20)
Biosensors Reports Financial Results for the Third Quarter of Fiscal Year 2015
PR Newswire - Thu Feb 12, 8:42AM CST
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced financial results for the third quarter of its Fiscal Year 2015 ("Q3 FY15" and nine months ended 31 December 2014 ("FY15 nine-month period" .
Kevin Sayer Assumes Role of President and Chief Executive Officer; Terry Gregg Transitions to Role of Executive Chairman
BusinessWire - Mon Jan 05, 7:31AM CST
DexCom, Inc. (NASDAQ
XCM) today announced that Kevin Sayer, currently the Company's President and Chief Operating Officer, has assumed the role of President and Chief Executive Officer to succeed Terry Gregg, who is transitioning to the role of Executive Chairman after more than seven years of service as DexCom's President and Chief Executive Officer.
DXCM: 90.53 (-0.39), SP: 24.95 (-0.06)
Biosensors Reports Financial Results for the Second Quarter and First Half of Fiscal Year 2015
PR Newswire - Wed Nov 12, 5:48AM CST
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced financial results for the second quarter of its Fiscal Year 2015 ("Q2 FY15" and first half ended 30 September 2014 ("H1 FY15" .
Biosensors Announces Strategic Agreement With Cardinal Health
PR Newswire Europe - Thu May 12, 8:01AM CDT
Biosensors International Group, Ltd. ("Biosensors" or the "Company"
, a developer, manufacturer and marketer of innovative medical devices, today announced that it has entered into a strategic distribution agreement with Cardinal Health. Vascular and Non-Vascular Stents: Global Market 2015 - Forecast to 2021
M2 - Mon Oct 19, 5:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cc3t5b/vascular_and) has announced the addition of the "Vascular and Non-Vascular Stents Global Market - Forecast to 2021" report to their offering. Stents are devices used in the body for treating weak or narrow blood vessels caused due to plaque formation. Stents helps in improvement of the blood flow and prevents the blood vessels from bursting. The global stents market is segmented based on the types, applications, materials, coatings, and geography. Based on the types, the stents are divided into bare metal stents, drug-eluting stents and bio-resorbable stents. By applications, the stents are divided into two segments as vascular and non-vascular stents. Vascular stents are further classified into coronary stents and peripheral stents. Peripheral stents are lower extremity & iliac stents, neurovascular stents and renal artery stents. Neurovascular stents sub segmented into carotid stents and intracranial stents. Non-vascular stents are divided into gastrointestinal, airway, urology and ophthalmology & other stents. Gastrointestinal stents are further segmented into pancreatic & biliary, esophageal, colorectal and duodenal stents. Urology stents are further segmented into ureteral & urethral stents and prostate stents. Depending on its materials, there are Metals and Polymers. Metals are segmented as cobalt-chromium, nickel-titanium, platinum-chromium, stainless steel and others whereas polymers are segmented as durable polymer and bio-absorbable polymers. Based on the coating, there are coated stents and non-coated stents. Coated stents are further segmented into inorganic, polymer, polymer-free and other coated stents. Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Analysis 4 Stents Market, By Types 5 Stents Market, By Application 6 Stents Market, By Materials 7 Stents Market, By Coatings 8 Regional Market Analysis 9 Company Developments 10 Major Player Profiles - Abbott Laboratories - B. Braun Melsungen Ag - Biosensors International Group - Biotronik Se & Co. Kg - Boston Scientific Corpoartion - C.R.Bard Inc. - Cook Medical Inc - Johnson & Johnson (Cordis Corporation) - Medtronic Inc - Microport Scientific Corporation - Olympus Corporation - Terumo Corporation For more information visit http://www.researchandmarkets.com/research/cc...scular_and
BSX: 23.89 (+0.03), JNJ: 123.22 (-0.55), ABT: 45.04 (-0.01), MDT: 87.54 (-0.26)
BioFreedom(TM) Drug-Coated Stent Demonstrates Superior Safety and Efficacy with One-Month of DAPT in Patients at High Bleeding Risk
PR Newswire - Wed Oct 14, 1:30PM CDT
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, announced today that the LEADERS FREE clinical trial demonstrated superior safety and efficacy for BioFreedom(TM) compared with a bare-metal stent (BMS). The results were presented by Dr. Philip Urban, Principal Investigator for LEADERS FREE, at the 27th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation, and simultaneously published in the New England Journal of Medicine.
Biosensors: BMX-J to Commercialize in Japan Starting October 2015
PR Newswire - Tue Sep 29, 7:45AM CDT
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced that the Company will commercialize its BMX-J drug-eluting stent (DES) system in Japan starting 1 October 2015.
Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016
PR Newswire - Mon Aug 03, 6:12AM CDT
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced financial results for its first fiscal quarter ended 30 June 2015 ("Q1 FY16"
. Biosensors Reports Financial Results for Fiscal Year 2015
PR Newswire - Wed May 27, 6:22AM CDT
Biosensors International Group, Ltd. ("Biosensors " or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced financial results for its fourth fiscal quarter ("Q4 FY15"
and fiscal full year ended 31 March 2015 ("FY15" . Global Biochemical Sensors Market Forecast and Opportunities 2015-2020
M2 - Fri May 08, 9:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ctbmsf/global) has announced the addition of the "Global Biochemical Sensors Market Forecast and Opportunities, 2020" report to their offering. The global biochemical sensors market is projected to reach USD23.3 billion by 2020 Electrochemical, optical, thermal, and piezoelectric are the major types of biochemical sensors used across diverse applications. Growing health concerns, declining cost of devices coupled with miniaturization of biochemical sensing devices are few of the major factors expected to drive demand for biochemical sensors over the next five years. High accuracy, easy usability, higher sensitivity even at low analyte concentrations are boosting the adoption of biochemical sensors across diverse end use applications. Growing need for low-cost, easy to use, fast and reliable analytical tools has been paving the way for use of biochemical sensors for quantitative and qualitative determination of discrete analytes in clinical, agricultural, environmental, food and defense applications. Presently, biochemical sensors are being predominantly used in medical applications, however, their adoption is increasing in agricultural, nutritional and environmental sectors due to continuous emphasis on improving product quality and growing need to comply with legislative guidelines. Increasing research & development activities, rising government emphasis and increasing advancements in healthcare infrastructure are expected to drive the sales of biochemical sensors over next five years. Global Biochemical Sensors Market Forecast & Opportunities, 2020 discusses the following aspects about the global biochemical sensors market: - Global Biochemical Sensors Market Size, Share & Forecast - Segmental Analysis - By Product Type (Electro-chemical, Thermal, Piezoelectic, Optical, etc.) and By End Use (Medical, Environmental, Nutritional & Agricultural) - Regional Analysis (North America, Europe, Asia-Pacific & Rest of World) - Changing Market Trends & Emerging Opportunities - Competitive Landscape & Strategic Recommendations Market Trends & Developments - Development of Silicon Microsensors - Development of Optical Fibers - Automotive Biochemical Sensors Technology - Growing Demand of Personalized Medicine - Miniaturization of Biochemical sensors - Integration of Wireless Communications Systems - Mass Production of Biochemical sensors Competitive Landscape - Company Shares - Abbott Point of Care Inc - Smiths Medical Md, Inc - LifeSensors Inc - LifeScan Inc. - Medtronic plc - Boston Scientific Corporation - Nova Biomedical Corporation - Acon Laboratories, Inc - Bio-Rad Laboratories, Inc - Universal Biosensors, Inc - Bayer AG - Pharmaco-Kinesis Corporation - SensLab - BioDetection Instruments, Inc - Biosensor Laboratories Incorporated - ABTECH Scientific, Inc - NeuroSky, Inc. - Biosensors International Group, Ltd - Roche Diagnostics - Sysmex Corporation - YSI Life Sciences For more information visit http://www.researchandmarkets.com/research/ctbmsf/global
BSX: 23.89 (+0.03), MDT: 87.54 (-0.26)
Global Drug Eluting Stents (DES) Pipeline Review 2015
M2 - Tue Apr 28, 3:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/k44d7d/drug_eluting) has announced the addition of the "Drug Eluting Stents (DES) - Pipeline Review, 2015" report to their offering. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key drug eluting stents pipeline products. Scope: - Extensive coverage of the Drug Eluting Stents products under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Drug Eluting Stents and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry The report enables you to: - Formulate significant competitor information, analysis, and insights to improve R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of Drug Eluting Stents under development - Develop market-entry and market expansion strategies - Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline - In-depth analysis of the product's current stage of development, territory and estimated launch date Companies Featured: - Abbott Vascular Inc. - AlviMedica Medical Technologies Inc. - Amaranth Medical, Inc. - Arterius Ltd - Biosensors International Group, Ltd. - BioSurfaces, Inc. - Biotronik SE & Co. KG - Boston Scientific Corporation - CARDIONOVUM GmbH - CID S.r.l. - Contego Medical, LLC - DISA Vascular (Pty) Ltd. - Elixir Medical Corporation - Envision Scientific Pvt. Ltd - Eurocor GmbH - HangZhou HuaAn Biotechnology Co.,Ltd - Icon Interventional Systems, Inc. - ICON Medical Corp. - InspireMD, Inc. - IRAMED GmbH - Lepu Medical Technology (Beijing) Co., Ltd. - Medinol Ltd. - Medtronic plc - Meril Life Sciences Pvt. Ltd. - Micell Technologies, Inc. - Minvasys - NanoCoeur, Inc. - Northwestern University - OrbusNeich - REVA Medical, Inc. For more information visit http://www.researchandmarkets.com/research/k4...ug_eluting
BSX: 23.89 (+0.03), MDT: 87.54 (-0.26), NSPR: 0.16 (unch)
Leading 100 Medical Devices/Technology/Supplies Companies of Emerging Markets 2015
M2 - Wed Apr 15, 7:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w5kc32/emerging_markets) has announced the addition of the "Emerging Markets Medical Devices/Technology/Supplies 100: An Industry Report" report to their offering. Medical technology aims to improve the quality of healthcare provided. Recent advances in this industry globally are focusing on cost reduction, less-invasive treatment options, and reduction in hospital stays and rehabilitation process. Emerging markets are widely recognized as one of the most important growth frontiers for medical devices. The healthcare industry has long seen that emerging markets have great untapped potential. In recent years many medical device companies have also begun to realize this potential and shift not only manufacturing but research and development to these emerging economies. The medical devices industry has exhausted its market territory in North America and Europe. Thus it is looking to expand into emerging markets which have shown promise due to increased demand for the healthcare industry, by the ageing population. Emerging markets are now considered one of the most important areas for growth for medical devices market. With this special industry report, our endeavor is to provide the new investors globally with a complete resourceful research report for familiarizing with the present investment trends of the Emerging Markets companies in the medical industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical devices/technology/supplies companies of Emerging Markets - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances among Emerging Markets medical devices/technology/supplies companies - International presence of Emerging Markets medical devices/technology/supplies companies - R&D activities by Emerging Markets medical devices/technology/supplies companies Key Topics Covered: 1. Rankings of Emerging Markets Medical Devices/Technology/Supplies Companies 2. Stock Market Performance over 5 Years. Leading 25 Emerging Markets Medical Devices/Technology/Supplies Companies 3. Key News of Emerging Markets Medical Devices/Technology/Supplies Companies for Year 2014 4. Important Alliances among Emerging Markets Medical Devices/Technology/Supplies Companies 5. International Presence of Emerging Markets Medical Devices/Technology/Supplies Companies 6. Research and Development Activities by Emerging Markets Medical Devices/Technology/Supplies Companies 7. Mergers and Acquisitions among Emerging Markets Medical Devices/Technology/Supplies Companies Companies Mentioned (Partial List) - Advanced Technology Company (Kuwait) - Biosensors International Group Ltd (Singapore) - CPC Diagnostics Pvt. Ltd (India) - Enjoyor Co., Ltd. (China) - Excelsior Medical Company Limited (Taiwan) - Ginko International Co Ltd (Taiwan) - Guangdong Shirongzhaoye Co Ltd (China) - Kossan Rubber Industries Berhad (Malaysia) - Largan Precision Company Limited (Taiwan) - MediVed Innovations Private Limited (India) - Mindray Medical International Limited (China) - Ningbo David Medical Device Co Ltd (China) - Optics India Equipments Private Limited (India) - Phoenix Medical Systems Private Limited (India) - Pneumo Care Health Private Limited (India) - PT Perdana Bangun Pusaka (Konica) Tbk (Indonesia) - PW Medtech Group Ltd (Hong Kong) - Remi Elektrotechnik Ltd. (India) - Sekonix Co Ltd (South Korea) - Servo-Med Industries Private Limited (India) - Shandong Pharmaceutical Glass Co Ltd (China) - Shandong Weigao Group Medical Polymer Co Ltd (Hong Kong) - Shanghai Tofflon Science and Technology Co Ltd (China) - South India Surgical Company Ltd (India) - Spectro Lab Equipments Pvt Ltd (India) - Syneron Medical Ltd. (Israel) - Toshvin Analytical Private Ltd (India) - Vimta Labs Ltd. (India) - Vinjoh Healthcare Private Limited (India) - Wadegati Labequip Private Limited (India) For more information visit http://www.researchandmarkets.com/research/w5...ng_markets
ELOS: 7.01 (+0.10), MR: 27.94 (+0.07)
Top 100 Asia Medical Devices/Technology/Supplies Companies 2015
M2 - Tue Apr 07, 4:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wttv9s/asia_medical) has announced the addition of the "Asia Medical Devices/Technology/Supplies 100: An Industry Report" report to their offering. Medical technology aims to improve the quality of healthcare provided. Recent advances in this industry globally are focusing on cost reduction, less-invasive treatment options, and reduction in hospital stays and rehabilitation process. Medical device companies remain bullish about Asian markets, driven by ageing populations, growing middle classes and government investments in healthcare. Strong demand for Asian medical devices has delivered sales growth of 44.1% compared to North/South America and Europe/Middle East/Africa. In 2012, the total value of the ASEAN medical device market was more than US $4 billion and the value is expected to increase to US $8 billion by 2017. With this special industry report, our endeavor is to provide the new investors globally with a complete resourceful research report for familiarizing with the present investment trends of the Asian companies in the medical industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical devices/technology/supplies companies of Asia - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances among Asian medical devices/technology/supplies companies - International presence of Asian medical devices/technology/supplies companies - R&D activities by Asian medical devices/technology/supplies companies Key Topics Covered: 1. Rankings of Asian Medical Devices/Technology/Supplies Companies 2. Stock Market Performance over 5 Years. Leading 25 Asian Medical Devices/Technology/Supplies Companies 3. Key News of Asian Medical Devices/Technology/Supplies Companies for Year 2014 4. Important Alliances among Asian Medical Devices/Technology/Supplies Companies 5. International Presence of Asian Medical Devices/Technology/Supplies Companies 6. Research and Development Activities by Asian Medical Devices/Technology/Supplies Companies 7. Mergers and Acquisitions among Asian Medical Devices/Technology/Supplies Companies Companies Mentioned - Partial List - Alfresa Pharma Corp (Japan) - Ansell Limited (Australia) - Arts Optical International Holdings Limited (Hong Kong) - AS ONE CORPORATION (Japan) - Asahi Intecc Co., Ltd. (Japan) - Beijing Wandong Medical Equipment Co. Ltd. (China) - Biosensors International Group Ltd (Singapore) - Blue Sail Medical Co Ltd (China) - CHC Healthcare Group (Taiwan) - China Medical System Hldgs Ltd (Hong Kong) - China Medicine Health Industry Co. Ltd (China) - China National Medicines Corp Ltd (China) - Citadel Research And Solutions Private Limited (India) - Claris Lifesciences Ltd. (India) - Cochlear Limited (Australia) - Confident Dental Equipments Limited (India) - Da An Gene Co Ltd of Sun Yat-Sen University (China) - Dipped Products Plc (Sri Lanka) - Ebos Group Limited (New Zealand) - Enjoyor Co., Ltd. (China) For more information visit http://www.researchandmarkets.com/research/wt...ia_medical
Top 100 Global Medical Devices/Technology/Supplies Not Active in India 2015
M2 - Thu Apr 02, 8:25AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dgm6pr/global_medical) has announced the addition of the "Global Medical Devices/Technology/Supplies Not Active in India 100" report to their offering. The global size of the medical devices sector is predicted to reach US $400 billion this year. However, India - a key player in the global pharmaceuticals industry, of which medical devices used to be covered - is underperforming. The country's market share stood at US $6.3 billion in 2013, contributing around 7-8 percent to overall healthcare spending in India as opposed to the 18 percent contributed by pharmaceuticals. With per capita spending estimated to be at less than US $3, it is understandable that the government feels FDI is the only way to spur domestic growth. Despite such figures, India's medical devices sector is expected to experience unprecedented growth during the next decade. By 2025, the industry is projected to be worth US $50 billion. This can be attributed to the country's growing middle class, an increase in the number of hospitals and, consequently, a greater need for sophisticated medical devices and better healthcare. With this special industry report, our endeavor is to provide the new investors globally with a complete resourceful research report for familiarizing with the present investment trends of the global companies in the medical devices/technology/supplies industry, which they would find beneficial to pursue for making business decisions in this sector in India. Highlights: - Leading global 100 medical devices/technology/supplies companies with no presence in India - Integration of company news and industry news, as well as rankings - Important M&A and alliances among global medical devices/technology/supplies companies not active in India - International presence of global medical devices/technology/supplies companies not active in India - R&D activities by global medical devices/technology/supplies companies not active in India Key Topics Covered: 1: Rankings of Global Medical Devices/Technology/Supplies Companies Not Doing Business in India News Section: 2: Key News of Global Medical Devices/Technology/Supplies Companies Not Doing Business in India for Year 2014 3: Alliances among Global Medical Devices/Technology/Supplies Companies Not Doing Business in India 4: International Presence of Global Medical Devices/Technology/Supplies Companies Not Doing Business in India 5: Research and Development Activities by Global Medical Devices/Technology/Supplies Companies Not Doing Business in India 6: Mergers and Acquisitions among Global Medical Devices/Technology/Supplies Companies Not Doing Business in India Companies Mentioned: Partial List - Abaxis Inc (United States) - Abiomed, Inc. (United States) - Advanced Technology Company (Kuwait) - Align Technology, Inc. (United States) - American Science and Engineering, Inc. (United States) - Angiodynamics, Inc. (United States) - Ansell Limited (Australia) - Arseus NV (Belgium) - Arts Optical International Holdings Limited (Hong Kong) - Atrion Corporation (United States) - Austar Lifesciences Ltd (Hong Kong) - Bastide le Confort Medical (France) - Biosensors International Group Ltd (Singapore) - Cantel Medical Corp. (United States) - China Medicine Health Industry Co. Ltd (China) - China National Medicines Corp Ltd (China) - Cooper Companies Inc (United States) - Create Medic Co., Ltd. (Japan) - Cremer SA (Brazil) - Cryolife, Inc. (United States) For more information visit http://www.researchandmarkets.com/research/dg...al_medical
ALGN: 95.65 (+1.02), ABAX: 49.65 (-0.05), ASEI: 36.94 (+0.20), CMN: 71.76 (+0.04), COO: 180.81 (-1.43)
CREDIT II Stent Trial Completes Enrollment
PR Newswire - Wed Mar 11, 7:59AM CDT
JW Medical Systems Limited ("JWMS"
, a fully-owned subsidiary of Biosensors International Group, Ltd. ("Biosensors" or the "Company" (Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), has announced completion of patient enrollment in CREDIT II, the first randomized controlled trial ("RCT" involving the EXCEL II coronary stent. EXCEL II is the latest generation in the EXCEL family of biodegradable polymer drug-eluting stents ("BP-DES" , the leading BP-DES brand in China. Incorporating JWMS' latest technology, the EXCEL II stent features an abluminal coating of sirolimus combined with an optimized PLA biodegradable polymer, and is deployed from a new delivery system. Top 100 Global Medical Devices Not Active in India: 2015 Industry Report
M2 - Mon Mar 09, 5:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3gp8dw/global_medical) has announced the addition of the "Global Medical Devices Not Active in India 100: An Industry Report" report to their offering. In India, with a rising population level and higher national growth rates and income levels, the demand for medical devices is expected to grow at a rate of over 15% per year. Though India presents an attractive market opportunity for global medical device manufacturers, the country has never been able to tap into its potential as a domestic manufacturing base. Despite having a medical device market that ranks in the world's top 20, the industry has a long history of being under-resourced. Recently, in a bid to boost investment in the $7 billion medical device sector, the Indian government announced that foreign companies could now fully own existing medical device manufacturers in the country, without the need to get prior approvals. This easing of existing regulations has been done to encourage foreign direct investment since the domestic capital market was not able to provide the much needed investment in this sector. The international companies in this field would now be able to use India as a manufacturing base easily by either setting up facilities of their own or by acquiring domestic manufacturers. FDI inflow will spur R&D and manufacturing innovations, in turn increasing the efficiency and effectiveness of medical electronic products. Advancement of medical electronic product quality and associated successful diagnostic rates are expected to create a spurt in adoption. Report Highlights: - Leading global 100 medical devices companies with no presence in India - Integration of company news and industry news, as well as rankings - Important M&A and alliances among global medical devices companies not active in India - International presence of global medical devices companies not active in India - R&D activities by global medical devices companies not active in India Companies Mentioned - Sample of the Top 100 Companies - A&T Corporation (Japan) - Abaxis Inc(United States) - Abiomed, Inc. (United States) - Advanced Technology Company (Kuwait) - Alphatec Holdings, Inc. (United States) - American Science and Engineering, Inc. (United States) - Atricure, Inc. (United States) - Atrion Corporation (United States) - Austar Lifesciences Ltd (Hong Kong) - Bastide le Confort Medical (France) - Baumer S.A. (Brazil) - Bioquell plc(United Kingdom) - Biosensors International Group Ltd (Singapore) - Canon Electronics Inc.(Japan) - China Medicine Health Industry Co. Ltd(China) - China Renji Medical Group Limited (Hong Kong) - China Resources Wandong Medical Equipment Company Limited (China) - Compumedics Limited (Australia) - Corgenix Medical Corporation(United States) - Create Medic Co., Ltd. (Japan) For more information visit http://www.researchandmarkets.com/research/3g...al_medical
ATEC: 0.36 (+0.01), ABAX: 49.65 (-0.05), ASEI: 36.94 (+0.20)
Biosensors Reports Financial Results for the Third Quarter of Fiscal Year 2015
PR Newswire - Thu Feb 12, 8:42AM CST
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced financial results for the third quarter of its Fiscal Year 2015 ("Q3 FY15"
and nine months ended 31 December 2014 ("FY15 nine-month period" . Kevin Sayer Assumes Role of President and Chief Executive Officer; Terry Gregg Transitions to Role of Executive Chairman
BusinessWire - Mon Jan 05, 7:31AM CST
DexCom, Inc. (NASDAQ
XCM) today announced that Kevin Sayer, currently the Company's President and Chief Operating Officer, has assumed the role of President and Chief Executive Officer to succeed Terry Gregg, who is transitioning to the role of Executive Chairman after more than seven years of service as DexCom's President and Chief Executive Officer. DXCM: 90.53 (-0.39), SP: 24.95 (-0.06)
Biosensors Reports Financial Results for the Second Quarter and First Half of Fiscal Year 2015
PR Newswire - Wed Nov 12, 5:48AM CST
Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced financial results for the second quarter of its Fiscal Year 2015 ("Q2 FY15"
and first half ended 30 September 2014 ("H1 FY15" . 
